Clinical Trial Update: Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating vaccination with antigen-loaded dendritic cells for inoperable stage III/IV melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Antigen-loaded dendritic cell vaccine

Snippet

Sponsor: Prof. Dr. Silke Gillessen | Conditions: Melanoma | Phase 1, Phase 2 | Status: TERMINATED